Xiao-Feng Zhu Selected Research

Xiao-Feng Zhu Research Topics

Disease

76	Neoplasms (Cancer) 01/2024 - 02/2002
16	Nasopharyngeal Carcinoma 01/2019 - 05/2002
15	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 06/2003
13	Breast Neoplasms (Breast Cancer) 10/2021 - 08/2003
10	Carcinogenesis 01/2021 - 08/2003
6	Carcinoma (Carcinomatosis) 01/2022 - 04/2008
6	Colonic Neoplasms (Colon Cancer) 06/2016 - 08/2005
6	Osteosarcoma (Osteogenic Sarcoma) 05/2012 - 06/2004
6	Leukemia 01/2011 - 02/2002
5	Neoplasm Metastasis (Metastasis) 12/2021 - 06/2016
5	Infections 09/2015 - 05/2011
4	Osteoporosis 10/2023 - 04/2005
4	Lung Neoplasms (Lung Cancer) 10/2018 - 10/2009
3	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 04/2013
3	Melanoma (Melanoma, Malignant) 01/2022 - 01/2019
3	Hypertension (High Blood Pressure) 08/2021 - 04/2012
3	Colorectal Neoplasms (Colorectal Cancer) 12/2019 - 10/2009
3	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 01/2018 - 12/2005
3	Liver Neoplasms (Liver Cancer) 01/2018 - 12/2005
3	Lymphoma (Lymphomas) 09/2015 - 02/2006
3	Ovarian Epithelial Carcinoma 04/2013 - 06/2008
2	B-Cell Lymphoma (Lymphoma, B Cell) 03/2022 - 11/2015
2	Alcoholism (Alcohol Abuse) 01/2022 - 01/2020
2	Triple Negative Breast Neoplasms 11/2021 - 01/2020
2	Thrombosis (Thrombus) 01/2020 - 09/2011
2	Stomach Neoplasms (Stomach Cancer) 01/2020 - 12/2005
2	Peripheral Nerve Injuries 12/2019 - 06/2018
2	Anaplastic Thyroid Carcinoma 11/2019 - 08/2005
2	Adenocarcinoma of Lung 10/2018 - 12/2005
2	Type 2 Diabetes Mellitus (MODY) 01/2017 - 05/2011
2	End Stage Liver Disease 01/2017 - 05/2011
2	Chronic Hepatitis B 12/2011 - 12/2011
2	Massive Hepatic Necrosis 09/2011 - 06/2000
2	Esophageal Squamous Cell Carcinoma 08/2011 - 02/2010
2	Graft vs Host Disease (Graft-Versus-Host Disease) 05/2011 - 03/2011
2	Acute Kidney Injury (Acute Renal Failure) 05/2011 - 10/2009

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 03/2022 - 04/2005
13	Phosphotransferases (Kinase)IBA 02/2023 - 05/2005
8	Beclin-1IBA 12/2021 - 06/2008
7	Biomarkers (Surrogate Marker)IBA 04/2024 - 08/2011
7	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2021 - 08/2003
6	Cisplatin (Platino)FDA LinkGeneric 03/2022 - 07/2007
6	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2021 - 07/2010
6	DNA (Deoxyribonucleic Acid)IBA 10/2018 - 12/2011
5	Caspase 3 (Caspase-3)IBA 03/2022 - 02/2002
5	Messenger RNA (mRNA)IBA 01/2017 - 04/2005
4	TOR Serine-Threonine KinasesIBA 01/2017 - 08/2012
4	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2017 - 05/2005
4	Small Interfering RNA (siRNA)IBA 09/2015 - 02/2006
4	hirsutanol AIBA 02/2013 - 07/2010
3	Sorafenib (BAY 43-9006)FDA Link 01/2024 - 05/2012
3	CateninsIBA 10/2023 - 11/2013
3	Transcription Factors (Transcription Factor)IBA 03/2022 - 06/2018
3	Factor VII (Proconvertin)IBA 03/2022 - 06/2018
3	LigandsIBA 01/2022 - 10/2009
3	TransferasesIBA 01/2017 - 08/2005
3	Topotecan (Hycamtin)FDA LinkGeneric 06/2016 - 10/2011
3	Tyrosine Kinase InhibitorsIBA 07/2015 - 02/2007
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 03/2015 - 08/2012
3	rhabdastrellic acid AIBA 08/2010 - 08/2007
3	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 10/2009 - 06/2008
3	Etoposide (VP 16)FDA LinkGeneric 02/2008 - 06/2004
3	manumycinIBA 08/2005 - 06/2003
2	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 03/2022
2	AcetogeninsIBA 01/2024 - 02/2002
2	Histones (Histone)IBA 01/2023 - 01/2021
2	Long Noncoding RNAIBA 12/2022 - 12/2019
2	6,7-dihydroxyflavoneIBA 01/2022 - 01/2021
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2022 - 01/2020
2	Ethanol (Ethyl Alcohol)IBA 01/2022 - 01/2021
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2021 - 08/2012
2	bafilomycin A1IBA 10/2021 - 01/2018
2	Autophagy-Related Protein-1 HomologIBA 10/2021 - 08/2011
2	CytokinesIBA 10/2021 - 01/2016
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2020 - 01/2017
2	Immune Checkpoint InhibitorsIBA 01/2019 - 01/2019
2	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2017 - 08/2012
2	Dasatinib (BMS 354825)FDA Link 11/2016 - 04/2013
2	AntioxidantsIBA 06/2016 - 03/2013
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2015 - 03/2013
2	N- (1- amino- 3- (2,4- dichlorophenyl)propan- 2- yl)- 2- (2- (methylamino)pyrimidin- 4- yl)thiazole- 5- carboxamideIBA 03/2015 - 08/2012
2	dactolisibIBA 03/2015 - 01/2013
2	LipidsIBA 03/2015 - 01/2012
2	apogossypoloneIBA 09/2014 - 01/2011
2	DiterpenesIBA 11/2013 - 04/2009
2	excisanin AIBA 11/2013 - 01/2013
2	SesquiterpenesIBA 02/2013 - 07/2010
2	Mitogen-Activated Protein KinasesIBA 08/2012 - 04/2009
2	ErbB-2 ReceptorIBA 05/2012 - 08/2003
2	Capsules (Microcapsules)IBA 04/2012 - 04/2005
2	Tacrolimus (Prograf)FDA LinkGeneric 03/2011 - 02/2008
2	GossypolIBA 01/2011 - 08/2009

Therapy/Procedure

14	Liver Transplantation 11/2023 - 06/2000
13	Therapeutics 01/2023 - 12/2007
7	Drug Therapy (Chemotherapy) 02/2023 - 05/2002
7	Immunotherapy 01/2023 - 01/2019
4	Transplantation 01/2017 - 12/2010
4	Aftercare (After-Treatment) 04/2012 - 01/2005
2	Operative Time 01/2020 - 05/2011
2	Hepatectomy 05/2011 - 12/2010